Skip to main navigation
Instil Bio logo
  • Home
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

News Releases

March 27, 2026
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
January 6, 2026
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco

Investor Tools

Instil Bio Instil Bio

Footer Menu

  • About
  • Contact Us

Site Social Media Links

  • LinkedIn LinkedIn
© 2026 Instil Bio. All Rights Reserved
Privacy Policy Terms of Service